Janumet 50/500Mg

Medicine Overview

Janumet 50/500 mg combines 50 mg of sitagliptin and 500 mg of metformin, providing effective dual-action management of type 2 diabetes. Sitagliptin increases insulin release and decreases glucagon levels, while metformin reduces glucose production in the liver and improves insulin sensitivity. This combination helps maintain stable blood sugar levels, reducing the risk of diabetes-related complications. Janumet 50/500 mg is suitable for adults seeking improved glycemic control alongside diet and exercise. Trusted for its safety and efficacy, Janumet supports better energy levels and overall metabolic health in diabetes management.